###begin article-title 0
The Core Binding Factor CBF Negatively Regulates Skeletal Muscle Terminal Differentiation
###end article-title 0
###begin p 1
Conceived and designed the experiments: SASA. Performed the experiments: OP VJ OAM CP PR LF SASA. Analyzed the data: OP VJ OAM CP PR LF SASA. Contributed reagents/materials/analysis tools: OP VJ OAM PR LF SASA. Wrote the paper: SASA.
###end p 1
###begin p 2
Current address: UMR7216 Epigenetique et Destin Cellulaire, Centre National de la Recherche Scientifique (CNRS) and Universite Paris-Diderot, Paris, France
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
Core Binding Factor or CBF is a transcription factor composed of two subunits, Runx1/AML-1 and CBF beta or CBFbeta. CBF was originally described as a regulator of hematopoiesis.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 424 427 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
Here we show that CBF is involved in the control of skeletal muscle terminal differentiation. Indeed, downregulation of either Runx1 or CBFbeta protein level accelerates cell cycle exit and muscle terminal differentiation. Conversely, overexpression of CBFbeta in myoblasts slows terminal differentiation. CBF interacts directly with the master myogenic transcription factor MyoD, preferentially in proliferating myoblasts, via Runx1 subunit. In addition, we show a preferential recruitment of Runx1 protein to MyoD target genes in proliferating myoblasts. The MyoD/CBF complex contains several chromatin modifying enzymes that inhibits MyoD activity, such as HDACs, Suv39h1 and HP1beta. When overexpressed, CBFbeta induced an inhibition of activating histone modification marks concomitant with an increase in repressive modifications at MyoD target promoters.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
Taken together, our data show a new role for Runx1/CBFbeta in the control of the proliferation/differentiation in skeletal myoblasts.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 244 247 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mikhail1">[1]</xref>
###xml 378 381 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang1">[2]</xref>
###xml 434 439 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx1</italic>
###xml 615 618 605 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Miyoshi1">[3]</xref>
###xml 620 623 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Golub1">[4]</xref>
###xml 749 752 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang2">[5]</xref>
###xml 754 757 744 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Okuda1">[6]</xref>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 600 605 <span type="species:ncbi:9606">human</span>
###xml 690 696 <span type="species:ncbi:10090">murine</span>
Runx1 (for Runt-related transcription factor 1, also known as AML1 for Acute Myeloid Leukemia 1, CBFA2 or PEPB2alphaB) belongs to a family of highly homologous heterodimeric transcription factors named Core Binding Factors or CBF (reviewed in: [1]). In addition to the Runx1 subunit which binds DNA directly, CBF is composed of a non-DNA-binding subunit named CBFbeta (CBFbeta) [2]. Runx1 binds better DNA in the presence of CBFbeta. Runx1 was originally identified at a breakpoint on human chromosome 21 in the t(8;21) translocation, known as the most common target of chromosomal translocations in human leukemia [3], [4]. Genetic studies showed that Runx1 is essential in the developing murine embryo for definitive hematopoiesis of all lineages [5], [6].
###end p 10
###begin p 11
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Komori1">[7]</xref>
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Chen1">[8]</xref>
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Theriault1">[9]</xref>
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang2">[5]</xref>
###xml 197 200 197 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Okuda1">[6]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ichikawa1">[10]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Raveh1">[11]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Osorio1">[12]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wotton1">[13]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-BritosBray1">[14]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Zhang1">[16]</xref>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
There is now strong evidence that Runx proteins are also important for differentiation of multiple cell types, including osteoblasts [7], neurons [8], [9], hematopoietic cells of all lineages [5], [6], [10] and skin epidermis and hair follicle stem cells [11], [12]. Runx1 is also involved in promoting senescence in primary mouse fibroblasts [13], and in cell cycle regulation [14]-[16].
###end p 11
###begin p 12
###xml 418 422 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Zhang2">[17]</xref>
###xml 424 428 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Lian1">[18]</xref>
Runx proteins have the potential to either activate or repress transcription in a context dependent manner. Runx1 seems to promote proliferation in progenitor cells, whereas in differentiating cells it cooperates with tissue-specific transcription factors to regulate tissue-specific gene expression. For example, Runx1 cooperates with C/EBPalpha and C/EBPbeta to regulate hematopoiesis and osteogenesis, respectively [17], [18]. The dual role of Runx1 in regulating proliferation and differentiation could depend on differential interactions with protein partners, specific for each stage of cell development. The molecular mechanisms underlying such a switch in Runx1 function remain however to be deciphered.
###end p 12
###begin p 13
###xml 75 79 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-GonzalezdeAguilar1">[19]</xref>
###xml 80 84 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Zhu1">[21]</xref>
###xml 119 123 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang3">[20]</xref>
###xml 358 362 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Buckingham1">[22]</xref>
###xml 472 476 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Smith1">[23]</xref>
###xml 780 784 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mal1">[24]</xref>
###xml 786 790 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ohkawa1">[25]</xref>
###xml 920 924 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mal1">[24]</xref>
###xml 926 930 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Zhang3">[26]</xref>
###xml 932 936 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-delaSerna1">[27]</xref>
###xml 1200 1204 1197 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mal1">[24]</xref>
###xml 1206 1210 1203 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Fulco1">[28]</xref>
###xml 1212 1216 1209 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Buckingham2">[29]</xref>
Runx1 and CBFbeta have also been linked to skeletal muscle differentiation [19]-[21], and prevention of muscle wasting [20]. In skeletal muscle, proliferation and differentiation are mutually exclusive. Indeed, skeletal muscle terminal differentiation begins with an irreversible withdrawal from the cell cycle, followed by muscle-specific marker expression [22]. Irreversible cell cycle exit involves a definitive silencing of proliferation-associated genes (reviewed in [23] and references therein). Terminal muscle differentiation is orchestrated by myogenic bHLH transcription factors, such as MyoD and Myf5, two master myogenic determination factors. MyoD is expressed in proliferating myoblasts, but is unable to activate its target genes even when bound to their promoters [24], [25]. MyoD therefore may have a repressive role at its target genes prior to initiating chromatin remodeling in differentiating cells [24], [26], [27]. In proliferating myoblasts, MyoD is associated with histone deacetylases (HDACs), the histone methyltransferase Suv39h1 and heterochromatin protein HP1, and might actively inhibit expression of its target genes by inducing a local repressive chromatin structure [24], [28], [29].
###end p 13
###begin p 14
Here we show that CBF associates with MyoD preferentially in proliferating myoblasts, and knockdown of Runx1 or CBFbeta accelerates cell cycle exit and terminal differentiation. Conversely, overexpression of CBF slows cell cycle exit and delays muscle differentiation. In proliferating myoblasts, the MyoD/CBF complex contains several chromatin modifying enzymes such as HDACs. In agreement with this, when overexpressed, CBFbeta maintains histone H3 hypoacetylated, hypomethylated on lysine 4 and hypermethylated on lysine 9, on MyoD target promoters, along with HDAC1 recruitment, even in differentiation conditions. Finally, Runx1 is recruited to MyoD target genes preferentially in proliferating myoblasts, when these genes are repressed. Altogether, our data suggest that CBF transcription factor plays a pivotal role as a negative regulator of skeletal muscle terminal differentiation.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
CBF Subunits, Runx1 and CBFbeta, Interact with MyoD in Proliferating Myoblasts
###end title 16
###begin p 17
###xml 172 181 172 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s001">Figure S1</xref>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s002">Figure S2</xref>
###xml 649 658 646 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1A</xref>
###xml 745 754 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1B</xref>
In an attempt to characterize MyoD protein partners, we carried out double-affinity purification of HA-Flag MyoD stably expressed in HeLa cells (see purification scheme on Figure S1). MyoD protein complex composition was then analyzed by mass spectrometry (MS) and western blot (WB). MS analysis of the purified protein complex revealed some already known partners of MyoD (Figure S2), such as Id, Pbx1, PC4 and E12/E47, and partners that had never been described to interact with MyoD. Indeed, MS analysis unveiled CBFbeta protein within MyoD complex with a high number of peptides, covering almost 20% of its protein mass and amino acids content (Figure 1A). WB analyses confirmed that result and showed that Runx1 also co-purified with MyoD (Figure 1B).
###end p 17
###begin title 18
###xml 37 45 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Runx1 and CBFbeta interact with MyoD in vitro and in proliferating myoblasts.
###end title 18
###begin p 19
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 107 109 104 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 289 291 286 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 971 980 952 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s008">Figure S8</xref>
###xml 983 985 964 966 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 1509 1511 1487 1489 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.</bold>
###xml 1553 1561 1528 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1592 1594 1567 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1804 1811 1779 1786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 1260 1266 <span type="species:ncbi:9986">rabbit</span>
A. Peptide sequences identified by mass spectrometry in the MyoD complex corresponding to CBFbeta protein. B. Western blot analysis of double-purified Flag-HA-MyoD (MyoD), or eluate from HeLa control cells (Mock) with the indicated antibodies (WB Ab). S: soluble; C: chromatin associated. C. HeLa cells stably expressing Flag-HA-CBFbeta (eCBFbeta) or HeLa control cells stably transfected with the empty vector (Ctr) were transiently transfected with expressing vectors for HA-tagged MyoD and/or HA-tagged Runx1. 24 hours post-transfection, cells were harvested and lysates were used for immunoprecipitation (IP) using Flag resin to precipitate Flag-HA-CBFbeta. Precipitates were then subjected to western blot using HA Ab (WB alpha-HA) to simultaneously detect HA-Runx1, HA-MyoD, and Flag-HA-CBFbeta (discriminated on the gel by their molecular weight). However, we have checked the identity of each HA-revealed band by using antibodies recognizing the native proteins (Figure S8). D. Nuclear extracts from proliferating (prolif.) or differentiating myoblasts (48 h, indicated as Diff.) were used for immunoprecipitation (IP) with antibodies (Ab) raised against MyoD (lanes 4 and 9) and Myf5 (lanes 2 and 7), with control beads (lanes 3 and 8) or with normal rabbit IgG (lanes 5 and 10) as negative controls. The resulting precipitates were then subjected to western blot analysis (WB) for the presence of MyoD, Myf5 and CBFbeta. Input extracts were loaded to show endogenous protein levels (lanes 1 and 6). E. Runx1, CBFbeta, or luciferase (Luc) were in vitro translated in the presence of 35S-Methionine (inputs on lanes 1-3, respectively) and incubated with equivalent amounts of GST-MyoD beads (lanes 4-7) or GST beads (lanes 8-11). GST pull-down was then conducted as described in the Material and Methods section, and the radiolabeled proteins were detected by autoradiography. *: CBFbeta.
###end p 19
###begin p 20
###xml 230 247 221 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1C, lane 6</xref>
###xml 359 376 347 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1C, lane 5</xref>
###xml 438 470 426 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1C, compare lanes 5 and 6</xref>
We then performed a complementary experiment by transfecting HA-tagged MyoD and/or HA-tagged Runx1 into HeLa cells stably expressing Flag-HA-CBFbeta (ectopic, eCBFbeta). We showed that, indeed, MyoD co-precipitated with eCBFbeta (Figure 1C, lane 6). Moreover, the simultaneous co-transfection of HA-tagged Runx1 resulted in its co-precipitation with CBFbeta (Figure 1C, lane 5) and, more importantly, increased the MyoD co-precipitation (Figure 1C, compare lanes 5 and 6).
###end p 20
###begin p 21
###xml 251 260 248 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s003">Figure S3</xref>
###xml 439 448 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1D</xref>
###xml 82 88 <span type="species:ncbi:10090">murine</span>
To further investigate the CBF/MyoD interaction, we turned to myogenic cells: the murine myoblastic cell line C2C12. Both CBFbeta and Runx1 are expressed in the C2C12 myoblasts and their protein level do not vary significantly during differentiation (Figure S3). We found that MyoD, and the other myogenic determination factor Myf5, co-precipitated with CBFbeta preferentially in proliferating compared to differentiating C2C12 myoblasts (Figure 1D).
###end p 21
###begin p 22
###xml 167 184 167 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1E, lane 4</xref>
###xml 209 226 206 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1E, lane 5</xref>
###xml 351 368 348 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1E, lane 8</xref>
###xml 411 428 408 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1E, lane 7</xref>
###xml 509 541 503 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1E, compare lanes 5 and 6</xref>
###xml 585 594 579 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1C</xref>
###xml 690 693 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
To assay whether MyoD has the ability to interact directly with CBF, we performed GST pull-down experiments, which showed that GST-MyoD strongly interacts with Runx1 (Figure 1E, lane 4), but not with CBFbeta (Figure 1E, lane 5). The interaction of MyoD with Runx1 was specific; we did not detect any Runx1 signal in the presence of GST protein alone (Figure 1E, lane 8) nor any luciferase signal with GST-MyoD (Figure 1E, lane 7). Interestingly, GST-MyoD interacts with CBFbeta only in the presence of Runx1 (Figure 1E, compare lanes 5 and 6), in agreement with our previous findings (Figure 1C). These results show that MyoD interacts directly with heterodimeric transcription factor CBF, via the Runx1 subunit.
###end p 22
###begin title 23
The bHLH and the Transactivating Domains of MyoD, and the Transcription Regulation Domain of Runx1 Are Required for Their Interaction
###end title 23
###begin p 24
###xml 359 368 356 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g002">Figure 2A</xref>
###xml 557 566 547 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g002">Figure 2A</xref>
###xml 791 800 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g002">Figure 2A</xref>
###xml 855 864 842 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1E</xref>
In an attempt to delimit the domain of MyoD responsible for interaction with Runx1, we used HA-tagged mutants of MyoD transfected into HEK 293 cells. Anti-HA immunoprecipitation revealed an interaction of Runx1 and CBFbeta with wild-type MyoD as expected, and only with a MyoD 82-318 mutant, which retains the bHLH and the C-terminal transactivating domains (Figure 2A). Runx1 and CBFbeta failed to interact with truncated MyoD versions lacking either the bHLH, i.e., mutants Nter and Cter, or the C-terminal domain, i.e., mutants DeltaCter, Nter and bHLH (Figure 2A). These experiments clearly show that the bHLH and the C-terminal transactivating domains are required for interaction with Runx1. Notably, MyoD deletion mutants that do not interact with Runx1 do not interact with CBFbeta (Figure 2A). This result, combined with the results presented on Figure 1E, indicate that Runx1 is most likely the subunit that directly interact with MyoD.
###end p 24
###begin title 25
The domains of MyoD and Runx1 involved in their interaction.
###end title 25
###begin p 26
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 125 134 122 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top panel</italic>
###xml 241 252 238 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower panel</italic>
###xml 378 389 372 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower panel</italic>
###xml 555 562 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 772 786 766 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">specific bands</italic>
###xml 788 790 782 784 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 906 915 900 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top panel</italic>
###xml 1042 1053 1036 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lower panel</italic>
###xml 1112 1120 1106 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1151 1153 1145 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1382 1389 1376 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
A. The bHLH domain and the C-terminal transactivating domain of MyoD are involved in the interaction with Runx1 and CBFbeta. Top panel, Schematic diagram of MyoD functional domains, TAD: transactivation domain, bHLH: basic Helix Loop Helix. Lower panel, Runx1 and CBFbeta interact with MyoD wild-type and with MyoD deletion mutant containing the bHLH and the C-terminal domain. Lower panel, expression vectors for wild-type MyoD and its deletion mutants were transfected in HEK 293 cells using Calcium phosphate precipitation as described in Material and Methods section. 48 h post-transfection, cells were lysed and lysates were subjected to anti-HA immunoprecipitation. Precipitates were then analyzed by western blotting using with the indicated antibodies (WB Ab). *: specific bands. B. The transcription regulation domain located in C-terminal part of Runx1 is required for the interaction with MyoD. Top panel, Schematic diagram of Runx1 protein. The Runt, transactivation (TA), and transcription inhibition (ID) domains are indicated. Lower panel, Runx1 and its deletion mutants, or luciferase (Luc) were in vitro translated in the presence of 35S-Methionine (inputs shown on the right panel) and incubated with equivalent amounts of GST-MyoD or GST agarose beads (normalization is shown in the lower panel). GST pull-down was then conducted as described in the Material and Methods section, and the radiolabeled proteins were detected by autoradiography.
###end p 26
###begin p 27
###xml 108 117 108 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g002">Figure 2B</xref>
###xml 261 270 261 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g002">Figure 2B</xref>
###xml 435 444 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g002">Figure 2B</xref>
To delimit the Runx1 domain involved in the interaction with MyoD, we performed a GST-pull down experiment (Figure 2B). Our results show that the transcription regulation domain located in the C-terminal part of Runx1 is required for the interaction with MyoD (Figure 2B). The interaction of MyoD with Runx1 was specific; we did not detect any Runx1 signal in the presence of GST protein alone nor any luciferase signal with GST-MyoD (Figure 2B).
###end p 27
###begin title 28
CBF Negatively Regulates Cell Cycle Exit and Terminal Differentiation in Skeletal Myoblasts
###end title 28
###begin p 29
###xml 102 111 102 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3A</xref>
###xml 113 137 113 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">see Runx1 quantification</italic>
###xml 210 219 210 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3A</xref>
###xml 340 349 340 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3A</xref>
###xml 354 364 354 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s004">Figure S4A</xref>
###xml 481 490 481 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3A</xref>
###xml 576 585 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3A</xref>
###xml 662 671 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3B</xref>
###xml 724 733 721 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3B</xref>
###xml 874 883 868 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3B</xref>
###xml 945 955 939 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s004">Figure S4B</xref>
###xml 1007 1016 1001 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3C</xref>
We used siRNAs to decrease Runx1 level in order to investigate its role in differentiating myoblasts (Figure 3A, see Runx1 quantification). Downregulation of Runx1 resulted in a more efficient differentiation (Figure 3A); both the expression of muscle markers and the proportion of multinucleated cells were higher in Runx1-depleted cells (Figure 3A and Figure S4A). In particular, myogenin and MCK (Muscle Creatine Kinase) were expressed at higher levels in Runx1-depleted cells (Figure 3A). Interestingly, cyclin D1 level decreased more rapidly when Runx1 is downregulated (Figure 3A). Similarly, CBFbeta downregulation induced an accelerated differentiation (Figure 3B, top panel) and a more rapid decrease in cyclin D1 (Figure 3B, lower panel). Indeed, we could detect MCK expression in CBFbeta-depleted myoblasts as soon as 24 h after the induction of differentiation (Figure 3B, top panel). These cells moreover exhibited larger myotubes (Figure S4B). We confirmed these results in primary myoblasts (Figure 3C).
###end p 29
###begin title 30
Downregulation of CBF subunits expression accelerates cell cycle exit and muscle terminal differentiation entry.
###end title 30
###begin p 31
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 499 501 495 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 570 572 563 565 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 848 850 838 840 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
A. C2C12 myoblasts were transfected with scrambled (Scr) or anti-Runx1 siRNAs. 48 h post-transfection (0 h, lanes 1-2), cells were placed in differentiation medium for 24 h (lanes 3-4) or 48 h (lanes 5-6). Cells were then analyzed by western blot with the indicated antibodies (WB Ab). The differentiation times are indicated in hours (h). Runx1 downregulation has been quantified (indicated as "Runx1 quantif.") using Bio1D application (Vilber Lourmat). alpha-tubulin is used as a loading control. B. As in A, except that we used two different CBFbeta siRNAs (C1, C2). C. As in A and B, except that we used proliferating primary myoblasts instead of C2C12 myoblasts, and combined Runx1 and CBFbeta siRNAs (lane 4). Note that all the kinetic studies of differentiation were carried out in the same 10 cm diameter cell culture dish for each sample. D. FACS analysis of the cell cycle distribution of C2C12 myoblasts transfected with the indicated siRNAs. Cells were analyzed 48 h post-transfection. Scr: scrambled siRNA.
###end p 31
###begin p 32
###xml 197 206 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g003">Figure 3D</xref>
In agreement with our previous results, we have found that Runx1 or CBFbeta downregulation led to a significant decrease of S-phase cells proportion concomitant with an increase in G1-phase cells (Figure 3D). This suggests that CBF positively regulates myoblasts proliferation.
###end p 32
###begin p 33
As for the specificity of the siRNAs, we obtained the same phenotype with three different siRNAs that target CBF: the two targeting CBFbeta subunit and the one targeting Runx1 subunit isoforms. Thus, the observed effects are unlikely due to any off-target effect.
###end p 33
###begin p 34
###xml 230 239 221 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s005">Figure S5</xref>
###xml 449 458 437 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4A</xref>
###xml 502 511 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4C</xref>
###xml 613 622 598 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4A</xref>
###xml 651 660 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4C</xref>
###xml 846 855 831 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4A</xref>
###xml 961 970 943 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4B</xref>
###xml 975 984 957 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s005">Figure S5</xref>
###xml 1022 1031 1004 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4B</xref>
###xml 1302 1317 1281 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4A and C</xref>
###xml 1416 1425 1392 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g004">Figure 4C</xref>
To complete our analysis, we studied the effect of CBFbeta overexpression on terminal differentiation. Overexpression of CBFbeta in C2C12 myoblasts (C2C12-CBFbeta) was well tolerated and did not lead to morphological abnormality (Figure S5). However, in differentiation conditions, C2C12-CBFbeta cells showed a delay in cell cycle exit, as measured by early-G1 phase cyclin D1 level that decreased with a 24 to 48 h delay compared to control cells (Figure 4A), but not that of late-G1 cyclins A and E (Figure 4C). Note that proliferating C2C12-CBFbeta cells contain more cyclin D1 protein then the control cells (Figure 4A), but not cyclins A2 and E (Figure 4C). The delayed cell cycle exit correlated with delayed expression of muscle markers such as myogenin (48 h delay), MCK (24 h delay), and MHC (Myosin Heavy Chain, not detected at 120 h) (Figure 4A). In contrast to control cells, C2C12-CBFbeta cells exhibited smaller and mainly mononucleated myotubes (Figure 4B and Figure S5) with low expression of MCK and MHC (Figure 4B) in differentiation conditions. This suggests that differentiation kinetics was not completely impaired but greatly delayed when CBFbeta was overexpressed. Further analysis of cell cycle regulators expression showed that, in addition to a delayed decrease in cyclin D1 (Figure 4A and C), cyclin D3 and p21 expression is delayed in C2C12-CBFbeta cells compared to C2C12 control cells (Figure 4C).
###end p 34
###begin title 35
Overexpression of CBFbeta delays cell cycle exit and muscle terminal differentiation.
###end title 35
###begin p 36
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C.</bold>
A-C. C2C12 cells stably overexpressing Flag-HA-CBFbeta (C2C12-CBFbeta) or control cells (C2C12-Ctr) were differentiated at the indicated times (in A and C, in hours), and analyzed by western blotting with the indicated antibodies (WB Ab) (A, C) or by immunofluorescence (IF) (63x magnification) (B). The kinetic studies were carried out in the same 10 cm diameter cell culture dish (A, C). IF experiments using anti-MCK or anti-MHC antibodies were performed 48 h and 72 h respectively after induction of differentiation. Cells were DAPI-stained prior to fluorescent microscopy analysis (63x magnification).
###end p 36
###begin p 37
Altogether, these results suggest that CBF plays a dual role during skeletal muscle differentiation by regulating cell cycle withdrawal and expression of muscle markers.
###end p 37
###begin title 38
CBF Transcription Factor Is Located to MyoD Early Target Genes and Regulates Negatively Their Expression
###end title 38
###begin p 39
###xml 227 236 227 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 351 361 351 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s006">Figure S6A</xref>
###xml 532 540 532 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cycD3</italic>
###xml 622 631 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5A</xref>
###xml 733 743 733 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s006">Figure S6B</xref>
The fact that CBF is a transcription factor which interacts with MyoD preferentially in proliferation conditions, led us to investigate whether it would be targeted to MyoD target genes to repress their transcription. Using an in silico approach, we first found that on early target gene promoters of MyoD, Runx1 and MyoD binding sites were adjacent (Figure S6A). In order to test the effective recruitment of Runx1 onto MyoD target promoters, we performed ChIP experiments. Our results showed a preferential enrichment in Runx1 on myogenin, p21 and cycD3 promoters in proliferating compared to differentiating myoblasts (Figure 5A). These MyoD target genes are expressed early in differentiating but not in proliferating myoblasts (Figure S6B).
###end p 39
###begin title 40
CBF acts at the chromatin level to regulate MyoD target genes.
###end title 40
###begin p 41
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 176 185 176 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">36B4</italic>
###xml 360 362 360 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 606 608 600 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 861 869 852 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 871 875 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myog</italic>
###xml 879 888 870 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 893 896 884 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 995 997 986 988 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 1346 1354 1334 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 1359 1368 1347 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 1545 1549 1533 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">36B4</italic>
A. ChIP using anti-Runx1 Ab were performed from either proliferating (grey bars) or differentiating myoblasts (black bars). We quantified copy numbers of the myogenin, p21 and cyclin D3 promoter regions harboring the MyoD and Runx1 target sequences, compared to 36B4 gene, which was used as a reference gene. Results are the mean of 3 independent experiments. B. Western blot analysis with the indicated antibodies (WB Ab) of Flag-purified Flag-HA-CBFbeta stably expressed in C2C12 cells (CBFbeta), or from C2C12 control cells (Ctr). Both inputs are probed in lanes 1-2 and eluates are shown in lanes 3-4. C. Chromatin immunoprecipitation (ChIP) experiments using anti-acetyl H3 antibody were performed from either proliferating (grey bars) or differentiating (black bars) C2C12 control (left) and C2C12-CBFbeta (right) cells. We quantified copy numbers of the myogenin (myog.), cyclin D3 and p21 promoter regions harboring the MyoD target sequences. Results are the mean of three measurements. D. ChIP experiments using antibodies against acetyl histone H3 (AceH3), trimethylated histone 3 lysine 4 (me3H3K4), trimethylated histone 3 lysine 9 (me3H3K9), Histone Deacetylase 1 (HDAC1) were performed from differentiating C2C12 control (grey bars) or C2C12-CBFbeta (black bars) cells (48 h differentiation time). We quantified copy numbers of the myogenin and cyclin D3 promoter regions harboring the MyoD target sequences. Results with the transcription activating marks (AceH3 and me3H3K4) were normalized using the expressed housekeeping gene 36B4, while the repressive marks (me3H3K9 and HDAC1) were normalized using the repressed major satellite repeats. Results are the mean of three measurements.
###end p 41
###begin p 42
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Desmin</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK</italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cycD3</italic>
Our ChIP assays showed that Runx1 was not located on late target genes of MyoD, such as Desmin, MHC and MCK (data not shown), while it was on early muscle differentiation genes myogenin, p21 and cycD3. In addition, we did not find Runx1 binding sites adjacent to E-boxes on late MyoD target genes' promoters. These findings suggest that Runx1 would essentially regulate early events of skeletal muscle terminal differentiation. Taken together, our results strongly suggest that Runx1 could be recruited onto MyoD early target genes to regulate negatively their expression in proliferating myoblasts.
###end p 42
###begin p 43
###xml 150 153 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 272 281 263 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5B</xref>
###xml 552 561 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5B</xref>
###xml 686 690 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-ReedInderbitzin1">[30]</xref>
###xml 742 746 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yahi1">[31]</xref>
###xml 747 751 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ayyanathan1">[33]</xref>
To gain insights into the mechanism of action of CBF on MyoD target genes, we purified CBFbeta protein complex from proliferating C2C12-CBFbeta cells via its Flag tag. As expected, CBFbeta co-purified with the myogenic factor MyoD and with its dimerization partner Runx1 (Figure 5B). The other partners that co-purified specifically with CBFbeta are proteins known to be involved in transcriptional repression: the histone 3 lysine 9 (H3K9) methyltransferase Suv39h1, the heterochromatin protein HP1beta, and the histone deacetylases HDACs 1, 2 and 3 (Figure 5B). These interactions could be mediated by Runx1. Indeed, these proteins are already known partners of Runx1 on the one hand [30], and repressors of MyoD activity on the other hand [31]-[33].
###end p 43
###begin p 44
###xml 354 362 348 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 364 373 358 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 378 381 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 547 556 538 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5C</xref>
###xml 723 731 714 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 736 745 727 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 806 815 794 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5D</xref>
###xml 919 928 907 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5D</xref>
Given the association of CBFbeta with chromatin-modifying enzymes, we studied the chromatin status of three target gene promoters of MyoD in differentiating C2C12-CBFbeta using chromatin immunoprecipitation (ChIP). Our results showed that, in contrast to control cells in which histone H3 acetylation (a mark associated with transcription activation) on myogenin, cyclin D3 and p21 promoters increased in differentiation compared with proliferation conditions, histone H3 acetylation levels at these promoters did not vary in C2C12-CBFbeta cells (Figure 5C). More generally, in differentiation conditions, we found that activating marks (histone H3 acetylation, histone H3 lysine 4 tri-methylation) are abnormally lower on myogenin and cyclin D3 promoters in C2C12-CBFbeta cells compared to control cells (Figure 5D). Concomitantly, repressive marks (histone H3 lysine 9 tri-methylation, presence of HDAC1) are higher (Figure 5D).
###end p 44
###begin p 45
###xml 147 156 144 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Figure 5B</xref>
These results are in agreement with our findings showing that CBF associates with chromatin modifying enzymes, such as HDACs, Suv39h1 and HP1beta (Figure 5B), which are known to repress MyoD activity in proliferating myoblasts. Thus, CBF has an effect on the chromatin structure of three early target genes of MyoD and contributes to maintain a repressive chromatin state.
###end p 45
###begin title 46
Runx1 Represses MyoD Transcriptional Activity
###end title 46
###begin p 47
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 255 265 255 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s006">Figure S6A</xref>
###xml 503 511 503 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 558 566 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g006">Figure 6</xref>
###xml 702 705 702 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV</italic>
###xml 702 705 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To investigate the effects of Runx1 on MyoD transcriptional activity, we used a luciferase reporter gene under the control of the myogenin promoter, which is a direct target promoter of MyoD that harbors a Runx-binding site adjacent to MyoD-binding site (Figure S6A). Co-transfection experiments were performed in HeLa cells line that does not express MyoD endogenously. We observed that the co-transfection of Runx1-expressing plasmid together with MyoD expression vector resulted in the inhibition of myogenin promoter activity in a dose-dependent manner (Figure 6). The inhibitory effect of Runx1 is specific and is MyoD-dependent. Indeed, it was not seen with Renilla-luciferase expression under a CMV promoter (used as a normalization control for transfection efficiency). Thus, Runx1 inhibits MyoD activity.
###end p 47
###begin title 48
Runx1 represses MyoD-mediated transcription.
###end title 48
###begin p 49
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV</italic>
###xml 538 541 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Co-transfection into HeLa cells with a myogenin promoter-driven Firefly luciferase reporter plasmid (kind gift of V. Sartorelli, NIH) without or with a fixed amount of MyoD expression vector (800 ng), and increasing amounts of vector expressing Runx1. The quantities of Runx1 expression vector used were: 0, 30, 60, 150, and 300 ng. The total amount of plasmid was normalized when necessary to 300 ng with the empty vector. The inhibitory effect of Runx1 was specific, indeed, it was not seen with a Renilla luciferase expression under a CMV promoter (used as a normalization control for the transfection). Results are the mean of 2 independent experiments performed each in triplicates.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
Here we show that CBF transcription factor, composed of Runx1 and CBFbeta subunits, is expressed in proliferating myoblasts where it interacts with MyoD. Modulating the expression levels of either Runx1 or CBFbeta impaired cell cycle exit and terminal myogenic differentiation.
###end p 51
###begin title 52
Runx1/CBFb Interact with MyoD
###end title 52
###begin p 53
###xml 311 315 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang3">[20]</xref>
###xml 330 335 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx1</italic>
###xml 381 385 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ishibashi1">[34]</xref>
###xml 542 546 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Lee1">[35]</xref>
###xml 640 644 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Lee1">[35]</xref>
###xml 645 649 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Tanaka1">[37]</xref>
###xml 777 781 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Inoue1">[38]</xref>
###xml 782 786 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Le1">[42]</xref>
###xml 1025 1029 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang3">[20]</xref>
###xml 1045 1049 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Wang3">[20]</xref>
###xml 1202 1210 1196 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">knock-in</italic>
###xml 1245 1250 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx1</italic>
###xml 1286 1291 1280 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx1</italic>
###xml 1349 1352 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK</italic>
###xml 1480 1485 1474 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx1</italic>
###xml 1550 1553 1544 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK</italic>
###xml 1222 1226 <span type="species:ncbi:10090">mice</span>
Mass spectrometry analysis revealed that CBFbeta is part of MyoD complex. Further western blot analyses of the same MyoD complex revealed the presence of Runx1 subunit. We have narrowed our study to Runx1 because of all the three Runx proteins, to our knowledge, Runx1 is the only one linked to skeletal muscle [20]. In addition, Runx1 is one of the MyoD target genes in myoblasts [34]. Among the other Runx members, Runx2 is mainly involved in osteogenesis, and it has already been shown that Runx2 expression is not detectable in myoblasts [35]. Moreover, ectopic expression of Runx2 in myoblasts triggers osteogenic transdifferentiation [35]-[37]. Finally, concerning Runx3, it has been shown that it is not expressed in skeletal muscle and is mainly linked to neurogenesis [38]-[42]. Thus, we explored the role of Runx1/CBFbeta during muscle skeletal terminal differentiation. However, Runx1 has been reported to play an important role in protecting denervated, fully differentiated, myofibers from atrophy and autophagy [20]. In this paper [20], Runx1 has been assigned a role of a growth-promoting factor of muscle cells to limit muscle wasting. In this very elegant study, the authors generated knock-in homozygous mice carrying inactive Runx1 in skeletal muscle cells. However, Runx1 inactivation was conducted under the indirect control of MCK promoter, which is active only at late stages of terminal differentiation. Thus, with this system, we cannot see the effect of Runx1 inactivation on early stages of terminal differentiation, where MCK promoter is not yet active.
###end p 53
###begin title 54
Runx1 and CBFb Regulate Cell Cycle Exit and Terminal Differentiation
###end title 54
###begin p 55
###xml 854 858 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Halevy1">[43]</xref>
###xml 860 864 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Cenciarelli1">[44]</xref>
###xml 1096 1099 1078 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1133 1136 1115 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1141 1150 1123 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 1192 1196 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Halevy1">[43]</xref>
###xml 1198 1202 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Cenciarelli1">[44]</xref>
###xml 1434 1443 1416 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s007">Figure S7</xref>
Runx1 or CBFbeta downregulation in myoblasts induced an accelerated cell cycle exit. Indeed, cyclin D1 protein disappears 24 h earlier in differentiation conditions. In addition, Runx1 or CBFbeta downregulation led to a an increase in G1-phase cells, suggesting that CBF promotes myoblasts proliferation. Conversely, CBFbeta overexpression delayed the early-G1 phase cyclin D1 disappearance in differentiation conditions (cyclin D1 is still detectable 72 hours after the induction of differentiation), but not that of late-G1 and early-S phase cyclins A2 and E1. Note that proliferating C2C12-CBFbeta cells contain more cyclin D1 protein, but not cyclins A2 and E, than the control cells. Together, these results suggest that CBFbeta overexpression impacts on early G1 markers. In addition, expression of the cell cycle exit regulators p21 and cyclin D3 [43], [44] is delayed in differentiating CBFbeta-overexpressing cells, suggesting a delayed or impaired cell cycle exit and terminal differentiation entry. In agreement with this, our ChIP results showed that in proliferating myoblasts, CBF (via Runx1) is recruited to repressed p21 and cyclin D3, which encode cell cycle exit regulators [43], [44]. Together, these results suggest that CBF regulates positively proliferation, and negatively terminal differentiation, of skeletal myoblasts. Thus, CBF impacts on the proliferation/differentiation switch in myoblasts (see model on Figure S7).
###end p 55
###begin p 56
###xml 463 467 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yoshida1">[45]</xref>
###xml 638 642 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Buckingham3">[46]</xref>
###xml 699 703 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Chiba1">[47]</xref>
In differentiation conditions, C2C12-CBFbeta cells showed delayed molecular differentiation (expression of muscle markers), and delayed appearance of myotubes that are abnormally small and mainly mono-nucleated. One alternative explanation is that these cells managed to differentiate correctly, although in a delayed manner, but exhibited a specific block in fusion and multi-nucleation. Indeed, CBFbeta subunit is retained in the cytoplasm by cortical filamins [45]. In muscle cells notably, structural proteins and cell adhesion proteins are required for the reorganization of the cell cytoskeleton during cell fusion to form myotubes [46]. Some studies do suspect a cytoplasmic role for CBFbeta [47]. Thus, CBFbeta overexpression in myoblasts, especially in the cytoplasm, could have a role in impairing the correct cytoskeleton reorganization during fusion. This could explain the phenomenon we observe in differentiating CBFbeta-overexpressing myoblasts. Moreover, we observed a very low expression of myogenin transcription factor in myoblasts overexpressing CBFbeta and since that myogenin is involved in cell fusion, this is an alternative explanation of the observed the mono- or di-nucleated myotubes.
###end p 56
###begin title 57
CBF Regulates Muscle Differentiation via a Direct Interaction between MyoD and the Runx1 Subunit
###end title 57
###begin p 58
Our results revealed that the role of CBF in myoblasts is likely to be partly mediated through direct interaction with MyoD. GST pull-down experiments showed that MyoD interacts directly with Runx1 subunit, but not with CBFbeta. This is confirmed by the use of MyoD deletion mutants in living cells. Indeed, MyoD deletion mutants that fail to interact with Runx1 do not interact neither with CBFbeta. MyoD/Runx1 interaction implicates the bHLH and the C-terminal transactivating domains of MyoD, and the transcription regulation domain of Runx1.
###end p 58
###begin p 59
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mal1">[24]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Zhang3">[26]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yahi1">[31]</xref>
###xml 459 467 459 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 469 472 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 477 486 477 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D3</italic>
###xml 505 514 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s007">Figure S7</xref>
###xml 609 631 609 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acetylcholine receptor</italic>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Simon1">[48]</xref>
###xml 1065 1069 1062 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mal1">[24]</xref>
###xml 1071 1075 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yahi1">[31]</xref>
###xml 1077 1081 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Mal2">[49]</xref>
###xml 1083 1087 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Puri1">[50]</xref>
###xml 1130 1134 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-ReedInderbitzin1">[30]</xref>
###xml 1136 1140 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Chakraborty1">[51]</xref>
###xml 1142 1146 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Taniuchi1">[52]</xref>
The preferential association of MyoD and CBF in proliferating myoblasts could mean that CBF might be acting as a negative co-factor of MyoD. Indeed, we provide evidence that CBF is recruited to early MyoD target genes, via Runx1, in proliferating myoblasts, where MyoD is mainly associated with transcriptional repressors [24], [26], [31]. This suggests that CBF may serve for assembly of a transcription repression complex at early MyoD target genes such as myogenin, p21 and cyclin D3 (see our model on Figure S7). As for example, such a mechanism could be involved in the repression of the skeletal muscle acetylcholine receptor gene, which contains a repressive E-box that mediates its repression in proliferating myoblasts [48]. In agreement with this, we found that in proliferating myoblasts, CBF associates with many chromatin modifying enzymes, such as Histone Deacetylases (HDACs 1, 2 and 3), the histone H3 lysine 9 (H3K9) methylase Suv39h1, and Heterochromatin Protein beta (HP1beta), which are known to repress MyoD activity in proliferating myoblasts [24], [31], [49], [50]; and already known to interact with Runx1 [30], [51], [52]. In agreement with this, in myoblasts overexpressing CBFbeta, histone H3 acetylation and its trimethylation on lysine 4 (marks of active transcription) are delayed on early MyoD target genes in differentiation conditions. Concomitantly, these genes remain abnormally marked by histone repressive marks (me3H3K9, HDAC1).
###end p 59
###begin p 60
Interestingly, although MyoD is expressed both in proliferating and differentiating cells, we found that the interaction between MyoD and CBF was lost in differentiating cells. In addition, we showed that overexpression of CBFbeta in myoblasts led to stabilization of Runx1 subunit that could more efficiently repress MyoD transactivating activity, which induces a delay in terminal differentiation. In agreement with this, we have shown that Runx1 represses MyoD activity in a gene reporter assay.
###end p 60
###begin p 61
We did not succeed to show the concomitant presence of Runx1 and MyoD on MyoD target genes, given that it has previously been demonstrated that in proliferating conditions, only a small fraction of MyoD contributes to the repressive remodeling of its target genes, prior differentiation. Alternatively, Runx1 could prevent the proper binding of MyoD and the recruitment of the transcriptional machinery. Notably, the displacement of Runx1 in differentiating conditions is concomitant with a strong binding of MyoD to its target promoters (data not shown).
###end p 61
###begin p 62
MyoD and Runx1 are both subject to post-translational modifications. Notably, MyoD is phosphorylated during the cell cycle while it becomes acetylated during differentiation. Runx1 can also be phosphorylated, acetylated or methylated, while these modifications still need to be characterized in muscle cells and during muscle differentiation. We propose that these modifications could favor or impair MyoD interaction with Runx1, respectively.
###end p 62
###begin title 63
Conclusion
###end title 63
###begin p 64
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Raveh1">[11]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Osorio1">[12]</xref>
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Chen1">[8]</xref>
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Theriault1">[9]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Hewitt1">[53]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Komaki1">[54]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Asakura1">[55]</xref>
Our findings concerning the role of CBF in the regulation of the proliferation/differentiation balance are in agreement with several reports. CBF was indeed implicated in skin epidermis and hair follicle differentiation [11], [12], as well as in neuronal differentiation [8], [9]. These data support an emerging role for Runx proteins in cell fate regulation in many cell lineages. Furthermore, MyoD was also shown to regulate osteogenic differentiation [53]. In addition, it has been shown that muscle satellite cells can differentiate into osteocytes or adipocytes under some conditions [54], [55]. Thus, our results point to a model in which CBF and myogenic bHLH protein families could act in concert to induce cell-lineage-specific gene expression, dependent on the extra-cellular stimuli.
###end p 64
###begin p 65
In summary, we propose that CBF transcription factor might participate in recruiting chromatin modifying enzymes to repress MyoD early target genes by locally inducing a repressive chromatin structure. Our data reveal a new critical role of CBF in the regulation of the balance between proliferation and differentiation in skeletal muscle cells. They also demonstrate a new mechanism of repression of differentiation genes in proliferating myoblasts.
###end p 65
###begin title 66
Methods
###end title 66
###begin title 67
Cell Culture
###end title 67
###begin p 68
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-AitSiAli1">[56]</xref>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
C2C12, HEK 293 and HeLa-S3 cells were cultured under standard conditions. C2C12 cells and mouse primary myoblasts were cultured and differentiated as described in: [56].
###end p 68
###begin title 69
Stable Cell Lines Establishment and Plasmid Construction
###end title 69
###begin p 70
###xml 339 343 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Robin1">[57]</xref>
A HeLa cell line stably expressing MyoD was established with a transgene encoding for full-length MyoD; and HeLa and C2C12 cell lines expressing CBFbeta were established with a transgene encoding for full-length CBFbeta. The transgenes were tagged with double-HA (Haemagglutinin) and double-FLAG epitopes at the N-terminus as described in [57].
###end p 70
###begin p 71
###xml 220 246 217 243 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCGCTCGAGCCGCGCGTCGTCCCGGG</named-content>
###xml 258 296 255 293 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ATTCTATATGCGGCCGCTAACGAAGTTTGAGATCATCG</named-content>
###xml 462 466 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Robin1">[57]</xref>
###xml 468 472 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ouararhni1">[58]</xref>
###xml 75 81 <span type="species:ncbi:10090">Murine</span>
Control cell lines transduced with the empty vector were also established. Murine CBFbeta cDNA (a kind gift from Dr Nancy A. Speck) was amplified by PCR with specific primers with protruding restriction sites (fw-Pspx1: CCGCTCGAGCCGCGCGTCGTCCCGGG, rev-Not1: ATTCTATATGCGGCCGCTAACGAAGTTTGAGATCATCG, and sub-cloned into the XhoI-NotI sites in the pREV retroviral vector after Pspx1 and Not1 digestion (Pspx1 is compatible with Xho cloning site in the pRev vector) [57], [58].
###end p 71
###begin title 72
Protein Complex Purification
###end title 72
###begin p 73
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yahi1">[31]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yahi1">[31]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Robin1">[57]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ouararhni1">[58]</xref>
###xml 390 399 390 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009425.s001">Figure S1</xref>
###xml 546 547 546 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 887 888 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1190 1194 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Robin1">[57]</xref>
###xml 1854 1858 1836 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Yahi1">[31]</xref>
Flag-HA-MyoD complex purification from HeLa-MyoD cells was performed as described in: [31]. Briefly, we used retroviral transduction strategy to establish HeLa-S3 cell lines expressing double tagged Flag-HA-MyoD [31], [57], [58], or a control cell line transduced with the empty pREV vector has been established. We carried out double-affinity purification of Flag-HA-MyoD from HeLa cells (Figure S1), using either nuclear soluble or chromatin fractions. For this, cells were resuspended in a hypotonic buffer (10 mM Tris-HCl pH 7.65; 1.5 mM MgCl2; 10 mM KCl) and disrupted with 20 strokes of a tight-fitting Dounce homogenizer. The cytosolic fraction was separated from nuclei by 7 min centrifugation at 4degreesC at 9000 rpm. The nuclear soluble fraction was obtained by incubation of the nuclear pellet in a high salt buffer (900 mM NaCl, 20 mM Tris pH 7.65, 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA), to get 300 mM NaCl, for 30 min at 4degreesC and centrifugation at 10,000 rpm. The resulting pellet, which corresponds to chromatin fraction, was resuspended and digested with micrococcal nuclease (Sigma, Saint-Quentin Fallavier, France), until it consisted primarily of mononucleosomes [57]. Nuclear soluble and chromatin fractions were then ultracentrifugated at 32000 rpm for 1 h at 4degreesC. Tagged-MyoD complex were then purified using anti-FLAG antibody immobilized on agarose beads (Sigma). After elution with the FLAG peptide (Ansynth, The Netherlands), the bound complexes containing nucleosomes were further affinity-purified on anti-HA antibody-conjugated agarose (Sigma) and eluted with the HA peptide (Ansynth, The Netherlands). Double-immunopurified complexes were resolved on 4-12% SDS-PAGE bis-Tris acrylamide gradient gel in MOPS buffer (Invitrogen), and stained using either the SilverQuest kit (Invitrogen, Cergy-Pontoise, France) [31], or with Colloidal blue (Invitrogen) for mass spectrometry (MS) analyses. In the latest, bands corresponding to proteins were cut from the gel, trypsin-digested using 0.4 mg of sequencing-grade trypsin (Promega, Charbonnieres, France), and identified by MS analysis.
###end p 73
###begin p 74
To purify CBFbeta complex from C2C12 cells, 3 grams of C2C12-CBFbeta cell pellet were used to purify tagged CBFbeta using a simple-affinity purification method using Flag resin.
###end p 74
###begin title 75
Preparation of Nuclear Extracts
###end title 75
###begin p 76
###xml 824 825 818 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were scraped in a minimal volume of PBS and centrifuged 2 min at 400 g. The pellet was resuspended in 5 volumes of: 20 mM HEPES pH 7, 0.15 mM EDTA, 0.15 mM EGTA, 10 mM KCl, then lysed by addition of NP-40 up to 4.5%. Nuclei were immediately neutralized with addition sucrose buffer (50 mM HEPES pH 7, 0.25 mM EDTA, 10 mM KCl, 70% (m/v) sucrose). After centrifugation (5 min, 2000 g), nuclei were suspended in glycerol buffer (10 mM HEPES pH 8, 0.1 mM EDTA, 100 mM NaCl, 25% glycerol) to remove any trace of cytosolic components and centrifuged again. The nuclei were then resuspended in sucrose buffer ndegrees2 (20 mM Tris pH 7.65; 60 mM NaCl; 15 mM KCl; 0.34 M Sucrose) then lysed in a final concentration of 250 mM NaCl using High Salt Buffer (20 mM Tris pH 7.65; 0.2 mM EDTA; 25% glycerol; 900 mM NaCl; 1.5 mM MgCl2). The lysates were sonicated 3 times for 15 s with the BioRuptor (Diagenode, Liege, Belgium) on "High", then centrifuged 10 min at 13000 rpm to harvest the total nuclear extracts (supernatants). Protein concentration for each sample was estimated with BCA kit (Perbio, Brebieres, France).
###end p 76
###begin title 77
Transient Transfections, Flag-Affinity Precipitation of Flag-HA-CBFb, HA-MyoD Precipitation
###end title 77
###begin p 78
###xml 276 285 269 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1C</xref>
###xml 116 119 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
For plasmid transfection, 25 microg of pRcCMV-HA-Runx1 (kind gift of Dr I. Kitabayashi, Japan), pCMV-HA-MyoD or pRC-CMV backbone were transfected into HeLa-CBFbeta cells, using calcium phosphate pH 7.12, and Flag IPs was performed 24 h post-transfection (results presented on Figure 1C). Each IP was performed with 1.5 mg of total nuclear extracts and with 25 microL stock of ssDNA and BSA-pre-blocked Agarose Flag M2 resin from Sigma. IP was performed on wheel overnight at 4degreesC. Resin was then washed 5 times with TEGN buffer (20 mM Tris pH 7.65; 0.1 mM EDTA; 10% glycerol; 150 mM NaCl; 0.5% NP-40) and eluted by competition with high-purity Flag peptide at a final concentration of 0.2 mg/ml. The resin-free eluate was retrieved using Clean-up Post reaction columns (Sigma).
###end p 78
###begin p 79
###xml 502 503 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For interaction experiments using MyoD deletion mutants, HEK 293 cells were transiently transfected using calcium phosphate at pH 7.12. We used for a 10-cm dish 5 microg of a pCMV-3HA-MyoD or its deletion mutants (Cter 241-318, Nter 1-66, bHLH 82-172, DeltaCter 1-240, DeltaNter 82-318), or the empty vector, along with 5 microg of pcDNA3-Runx1 and 5 microg of pcDNA3-CBFbeta vectors. 48 h post-transfection, cells were lysed in lysis buffer (300 mM NaCl, 50 mM Tris-HCl, pH 7.5, 0,4% NP-40, 10 mM MgCl2) to extract proteins. Anti-HA immunoprecipitation was then performed as described above.
###end p 79
###begin title 80
siRNA Transfection
###end title 80
###begin p 81
###xml 311 330 304 323 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCGGGAAUAUGUCGACUUA</monospace>
###xml 340 359 333 352 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAACUUAGGUGGCGGUGAU</monospace>
###xml 374 393 367 386 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUGUGAAUGCUUCUGAUUU</monospace>
###xml 420 441 413 434 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACUUAACCGGCAUACCGGCTT</monospace>
siRNAs were purchased from Sigma (Saint-Quentin Fallavier, France) and were transfected using Hi-Perfect reagent (Qiagen, Courtaboeuf, France) according to the manufacturer recommendations. We usually transfect 0.2 micromol of siRNA per 100 mm cell culture dish. CBFbeta targeting siRNA sequences used are: C1: CCGGGAAUAUGUCGACUUA, and C2: UAACUUAGGUGGCGGUGAU; Runx1 siRNA: CUGUGAAUGCUUCUGAUUU; and the scrambled siRNA: ACUUAACCGGCAUACCGGCTT.
###end p 81
###begin title 82
Immunoprecipitation of Endogenous Proteins
###end title 82
###begin p 83
For IP, we usually use 2 microg of antibodies, 10 microL protein A/G Sepharose beads from Perbio and 1.2 mg of nuclear extracts from C2C12 cells, or 0.5 mg from primary myoblasts. Elution was performed with 40 microl of 0.1 M glycine pH 2.5, 15 min at 25degreesC, the eluate was recovered using Spin cleaning-up post-reaction column (Sigma). Acidity was neutralized with Tris pH 8.0 before adding loading buffer.
###end p 83
###begin title 84
Western Blotting
###end title 84
###begin p 85
For western blotting, protein samples were resolved on pre-cast NuPage 4-12% bis-Tris acrylamide gradient SDS-PAGE gel (Invitrogen, Cergy-Pontoise, France). Proteins were then transferred onto nitrocellulose membrane during 1 h at 400 mA in transfer buffer (25 mM Tris, 150 mM Glycine, 0.1% SDS and 20% methanol). Membranes are blocked 1 hour in PBS-0.2% Tween, 10% skimmed milk and incubated overnight at 4degreesC with primary antibodies. Membranes were incubated with the appropriate secondary antibodies coupled to HRP and revealed using West Dura from Pierce (Perbio, Brebieres, France) and ChemiSmart 5000 system (Vilber Lourmat, Marne-La-Vallee, France).
###end p 85
###begin title 86
Plasmids, GST Fusions and GST Pull-Down
###end title 86
###begin p 87
###xml 54 70 54 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 285 293 285 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 451 459 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 534 536 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 54 82 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
GST and GST-MyoD plasmid constructs were expressed in Escherichia coli strain BL21 and purified using glutathione-sepharose beads according to the manufacturer (Sigma, Saint Quentin-Fallavier, France). Purified proteins were quantified by coomassie staining after SDS-PAGE separation. In vitro transcription and translation (TNT) of pcDNA3-Runx1 and its deletion mutants aa 1-189 and 1-242, pcDNA3-CBFbeta and luciferase were performed with Riboprobe in vitro transcription systems (Promega, Charbonnieres, France) in the presence of 35S-labelled methionine.
###end p 87
###begin p 88
Agarose beads coated with equal amounts of GST or GST-MyoD (1 microg) were incubated with 10 microL of radioactive TNT reaction in reaction buffer (50 mM Tris pH 7.6, 150 mM NaCl, 0.1% Triton) during 2 h at 4degreesC. Beads were washed 5 times with wash buffer (50 mM Tris pH 7.6, 300 mM NaCl, 0.5% Triton 100), resuspended and proteins resolved by SDS-PAGE gel and revealed by autoradiography.
###end p 88
###begin title 89
Immunofluorescence
###end title 89
###begin p 90
###xml 237 241 <span type="species:ncbi:9925">goat</span>
Cells were cultured in Labtecks permanox (Falcon) and fixed briefly with 4% formaldehyde in PBS. Residual formaldehyde was neutralized with 0.1 M Glycine pH 8.0, and washed with PBS. Cells were permeabilized and blocked using 1% BSA, 1% goat serum, 0.3% Triton-X100 in PBS. Primary and secondary antibodies were diluted in the permeabilizing/blocking solution and were washed with 0.3% Triton-X100 in PBS. Nuclei are stained with DAPI and the glass lid is fixed using an anti-fading polymerizing media from DakoCytomation (Dako, Trappes, France).
###end p 90
###begin title 91
Antibodies
###end title 91
###begin p 92
###xml 768 772 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-Ito1">[59]</xref>
###xml 241 247 <span type="species:ncbi:9986">rabbit</span>
###xml 321 327 <span type="species:ncbi:9986">Rabbit</span>
###xml 409 415 <span type="species:ncbi:9986">rabbit</span>
###xml 705 711 <span type="species:ncbi:9986">Rabbit</span>
###xml 879 882 <span type="species:ncbi:10116">Rat</span>
###xml 943 948 <span type="species:ncbi:10090">Mouse</span>
###xml 1049 1054 <span type="species:ncbi:10090">mouse</span>
###xml 1135 1139 <span type="species:ncbi:9925">Goat</span>
###xml 1145 1148 <span type="species:ncbi:10116">rat</span>
###xml 1180 1186 <span type="species:ncbi:9986">rabbit</span>
###xml 1256 1261 <span type="species:ncbi:10090">mouse</span>
The anti-MyoD (C-20), anti-myogenin (M-225), anti-Myf5 (C-20), anti-CBFbeta (FL-182), anti-cyclin A2 (C19, sc-596), anti-cyclin D1 (72-13G, sc-450), anti-cyclin D3 (C-16, sc-182), anti-cyclin E (sc-25303), anti-p21 (C-19, sc-397) and normal rabbit IgG antibodies were all purchased from Santa Cruz (Santa Cruz, CA, USA). Rabbit polyclonal anti-Suv39h1 (07-550), anti-trimethyl histone 3 lysine 9 (07-442) and rabbit anti-acetyl histone H3 (06-599) antibodies were obtained from Upstate Biotech (Lake Placid, NY, USA). Anti-HP1beta (1MOD1A9AS) was from Euromedex (Souffelweyersheim, France). Anti-HDAC1 (pAB-053-050) was from Diagenode (Liege, Belgium). Anti-trimethyl H3K4 was from Abcam (Paris, France). Rabbit polyclonal anti-MCK antibody was developed by Dr H. Ito [59]. Anti-Flag and anti-alpha-tubulin antibodies were purchased from Sigma (Saint-Quentin Fallavier, France). Rat anti-HA antibody was purchased from Roche (Meylan, France). Mouse anti-Runx1 antibody (MAB10062) was purchased from Millipore (Saint Quentin en Yvelines, France) and mouse anti-HDAC 1-3 antibody (611125) from BD Biosciences (Le Pont de Claix, France). Goat anti-rat IgG Alexa-488-conjugated, anti-rabbit IgG Alexa-488 were from Invitrogen (Cergy-Pontoise, France) and anti-mouse IgG TRITC (T7657) were from Sigma (Saint-Quentin Fallavier, France).
###end p 92
###begin title 93
FACS Analysis
###end title 93
###begin p 94
C2C12 were transfected with the siRNAs as indicated in the Material and Method section. 48 hours post-transfection, cells were washed with PBS, then scraped in 500 microL of PBS. Cells were kept on ice while 4,5 ml of ethanol 70% were added. Then cells are kept at least overnight at -20degreesC. Propidium iodide (PI) staining proceeds as follows: cells are centrifuged and the pellet is washed with PBS. Cells are then centrifuged and resuspended in 2 mL PI solution (PI 25 ng/ml, RNase 200 ng/ml, Triton 0,1%) 30 minutes and kept in the dark. Cells are homogeneized by vortexing before analysis. We worked on a Beckman and Coulter FACS apparatus and we counted at least 3000 events for each condition.
###end p 94
###begin title 95
Chromatin Immunoprecipitation (ChIP)
###end title 95
###begin p 96
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009425-AitSiAli1">[56]</xref>
###xml 107 128 107 128 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATCACATGTAATCCACGGA</monospace>
###xml 135 155 135 155 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACGCCAACTGCTGGGTGCCA</monospace>
###xml 171 190 171 190 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTGCTTGCCTCTGTCTTCA</monospace>
###xml 197 216 197 216 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GACCCATGTCAGATGACTC</monospace>
###xml 227 249 227 249 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATGTGCAGCTGATAAAGACTGG</monospace>
###xml 256 277 256 277 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTGTGATGTCGAGCACTTCAG</monospace>
ChIP protocol and primers have been described in: [56]. The yet unpublished primers used are: Myogenin fw: GAATCACATGTAATCCACGGA, rev: ACGCCAACTGCTGGGTGCCA. Cyclin D3 fw: CTGCTTGCCTCTGTCTTCA; rev: GACCCATGTCAGATGACTC. 36B4 fw: ATGTGCAGCTGATAAAGACTGG; rev: CTGTGATGTCGAGCACTTCAG.
###end p 96
###begin title 97
Gene Reporter Assays
###end title 97
###begin p 98
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenin</italic>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV</italic>
###xml 519 522 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
HeLa cells at 60% confluence were co-transfected by Calcium Phosphate co-precipitation with a myogenin promoter-driven Firefly luciferase reporter plasmid (kind gift of V. Sartorelli, NIH) without or with a fixed amount of MyoD expression vector (800 ng), and increasing amounts of vector expressing Runx1. The quantities of Runx1 expression vector used were: 0, 30, 60, 150, and 300 ng. The total amount of plasmid was normalized when necessary to 300 ng with the empty vector. A Renilla luciferase expression under a CMV (cytomegalovirus) promoter was used as a normalization control for the transfection. 24 h post-transfection, cells were lysed in a reporter lysis buffer (Promega, Charbonnieres, France). Luciferase activity was determined using Dual-Luciferase Reporter Assay System (Promega). Firefly luciferase activity was then normalized to the level of Renilla luciferase and to the total protein amount.
###end p 98
###begin title 99
Supporting Information
###end title 99
###begin p 100
Schematic representation of the purification protocol used to purify the MyoD complex from HeLa cells.
###end p 100
###begin p 101
(0.38 MB EPS)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
MyoD known partners identified by mass spectrometry in the MyoD complex.
###end p 103
###begin p 104
(0.05 MB DOC)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
Expression of Runx1 and CBFbeta proteins during muscle terminal differentiation. Cellular extracts from proliferating or differentiating C2C12 myoblasts (left panel) or from mouse primary myoblasts (right panel) were subjected to western blot analyses for the expression of CBFbeta, Runx1, MyoD, myogenin (Myog.) and Muscle Creatine Kinase (MCK). alpha-tubulin is detected as a loading control. Differentiation times are indicated in hours on the top of each panel. Lanes 1 and 7 correspond to proliferating cells.
###end p 106
###begin p 107
(0.57 MB EPS)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
Downregulation of CBF subunits expression accelerates muscle terminal differentiation entry. A. C2C12 myoblasts were transfected with control siRNA (Scrambled, Scr) or with Runx1 siRNA as indicated. 48 hours post-transfection (Proliferation) cells were placed in differentiation medium (Differentiation) for 86 hours. Cells were then analyzed by microscopy (10x magnification). B. As in A, except that we used CBFbeta siRNA.
###end p 109
###begin p 110
(11.55 MB EPS)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
C2C12-CBFbeta cells characterization. A. Expression level of CBFbeta in C2C12 control (ctr) and in C2C12-CBFbeta, in proliferating myoblasts (0 h) or at the indicate differentiation times (in hours), as measured by western blot using anti-CBFbeta antibody. ex.: exogenous; end: endogenous. B. C2C12 cells stably overexpressing Flag-HA-CBFbeta (C2C12-CBFbeta) or control cells (C2C12-Ctr) were differentiated for 72 hours and analyzed by light microscopy (10x magnification).
###end p 112
###begin p 113
(10.67 MB EPS)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
###xml 203 210 203 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g005">Fig. 5A</xref>
A. Runx1 and MyoD binding sites found in silico on MyoD target genes myogenin and p21. B. Western blot analysis (with the indicated antibodies) of cell extracts used for the ChIP experiment presented on Fig. 5A. alpha-tubulin (alpha-tub.) is used a loading control.
###end p 115
###begin p 116
(0.52 MB EPS)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
Proposed model of skeletal muscle terminal differentiation regulation by CBF and MyoD. Note that in muscle system, proliferation inhibition or cell cycle exit is a pre-requisite to terminal differentiation. Thus, cell cycle exit regulators, such as p21 and cycD3, are activated early during terminal differentiation. Muscle specific early markers, such as myogenin, are also activated before late muscle markers. In proliferating myoblasts, Runx1/CBFbeta (CBF dimer) proteins repress MyoD target genes, possibly via a direct interaction with MyoD. Thus, in proliferating myoblasts, CBF binds early MyoD target genes via Runx1 subunit and recruits chromatin modifying enzymes such as HDAC1, Suv39h1 and HP1. Upon triggering of terminal differentiation, CBF dissociates from the promoters and MyoD recruits activating chromatin modifying enzymes, such as HATs. HDAC1: Histone Deacetylase 1; HAT: Histone acetyltransferase.
###end p 118
###begin p 119
(0.54 MB EPS)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
###xml 57 66 57 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009425-g001">Figure 1C</xref>
Control of the anti-HA western blot results presented on Figure 1C using antibodies against native proteins: MyoD, CBFbeta and Runx1.
###end p 121
###begin p 122
(0.53 MB EPS)
###end p 122
###begin p 123
Click here for additional data file.
###end p 123
###begin p 124
We thank A. Polesskaya for technical help and critical reading of the manuscript. We thank F. Ferri and C. Guillemin for technical help. We thank C. Francastel, J. Weitzman, F. Hube, C. Rougeulle, V. Mezger and P.A. Defossez for critical reading of the manuscript. The authors warmly thank Drs N. Speck, Y. Ito, V. Sartorelli, G. Mouchiroud, SA. Leibovitch, I. Kitabayashi, H. Ito, and L. Delva for sharing reagents.
###end p 124
###begin title 125
References
###end title 125
###begin article-title 126
Normal and transforming functions of RUNX1: a perspective.
###end article-title 126
###begin article-title 127
The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.
###end article-title 127
###begin article-title 128
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.
###end article-title 128
###begin article-title 129
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
###end article-title 129
###begin article-title 130
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.
###end article-title 130
###begin article-title 131
###xml 59 64 <span type="species:ncbi:9606">human</span>
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
###end article-title 131
###begin article-title 132
Cbfa1 in bone development.
###end article-title 132
###begin article-title 133
Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain.
###end article-title 133
###begin article-title 134
Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system.
###end article-title 134
###begin article-title 135
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
###end article-title 135
###begin article-title 136
Dynamic expression of Runx1 in skin affects hair structure.
###end article-title 136
###begin article-title 137
Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation.
###end article-title 137
###begin article-title 138
RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
###end article-title 138
###begin article-title 139
CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents.
###end article-title 139
###begin article-title 140
The core binding factor (CBF) alpha interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFbeta-SMMHC are both required to slow cell proliferation.
###end article-title 140
###begin article-title 141
Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation.
###end article-title 141
###begin article-title 142
Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters.
###end article-title 142
###begin article-title 143
Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo.
###end article-title 143
###begin article-title 144
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.
###end article-title 144
###begin article-title 145
Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle.
###end article-title 145
###begin article-title 146
AML1 is expressed in skeletal muscle and is regulated by innervation.
###end article-title 146
###begin article-title 147
Skeletal muscle development and the role of the myogenic regulatory factors.
###end article-title 147
###begin article-title 148
###xml 96 101 <span type="species:ncbi:9606">human</span>
Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation.
###end article-title 148
###begin article-title 149
MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis.
###end article-title 149
###begin article-title 150
Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1.
###end article-title 150
###begin article-title 151
Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation.
###end article-title 151
###begin article-title 152
Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation.
###end article-title 152
###begin article-title 153
Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state.
###end article-title 153
###begin article-title 154
Skeletal muscle formation in vertebrates.
###end article-title 154
###begin article-title 155
RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription.
###end article-title 155
###begin article-title 156
Differential cooperation between heterochromatin protein HP1 isoforms and MyoD in myoblasts.
###end article-title 156
###begin article-title 157
###xml 85 92 <span type="species:ncbi:9606">patient</span>
A novel Wiskott-Aldrich syndrome protein (WASP) complex mutation identified in a WAS patient results in an aberrant product at the C-terminus from two transcripts with unusual polyA signals.
###end article-title 157
###begin article-title 158
Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation.
###end article-title 158
###begin article-title 159
MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.
###end article-title 159
###begin article-title 160
Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
###end article-title 160
###begin article-title 161
Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype.
###end article-title 161
###begin article-title 162
Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
###end article-title 162
###begin article-title 163
Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons.
###end article-title 163
###begin article-title 164
###xml 26 31 <span type="species:ncbi:9606">human</span>
AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.
###end article-title 164
###begin article-title 165
###xml 95 100 <span type="species:ncbi:9606">human</span>
A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1.
###end article-title 165
###begin article-title 166
AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
###end article-title 166
###begin article-title 167
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway.
###end article-title 167
###begin article-title 168
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
###end article-title 168
###begin article-title 169
Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation.
###end article-title 169
###begin article-title 170
Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor.
###end article-title 170
###begin article-title 171
Making muscle in mammals.
###end article-title 171
###begin article-title 172
Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2beta/CBFbeta, in muscle development.
###end article-title 172
###begin article-title 173
An E box mediates activation and repression of the acetylcholine receptor delta-subunit gene during myogenesis.
###end article-title 173
###begin article-title 174
Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.
###end article-title 174
###begin article-title 175
Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis.
###end article-title 175
###begin article-title 176
SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.
###end article-title 176
###begin article-title 177
Epigenetic gene silencing by Runx proteins.
###end article-title 177
###begin article-title 178
The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter.
###end article-title 178
###begin article-title 179
MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures.
###end article-title 179
###begin article-title 180
Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation.
###end article-title 180
###begin article-title 181
A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.
###end article-title 181
###begin article-title 182
Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a.
###end article-title 182
###begin article-title 183
The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity.
###end article-title 183
###begin article-title 184
Regulation of the levels of small heat-shock proteins during differentiation of C2C12 cells.
###end article-title 184
###begin p 185
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 185
###begin p 186
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Association Francaise contre les Myopathies (AFM); the Fondation Bettencourt-Schueller; the Agence Nationale de la Recherche (ANR); the Ligue Nationale contre le Cancer; the Association pour la Recherche sur le Cancer (ARC), the CNRS; the Universite Paris-Sud and the Universite Paris Diderot. PO was recipient of fellowships from the Ministere de la Recherche and the ARC. AO was recipient of a fellowship from the "Programme franco-algerien de formation superieure en France". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 186

